These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 8381060)

  • 1. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.
    Nuglozeh E; Gauquelin G; Garcia R; Tremblay J; Schiffrin EL
    Am J Physiol; 1990 Jul; 259(1 Pt 2):F130-7. PubMed ID: 2165357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
    Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The changes in natriuretic peptide receptors (NP-R) in the lung and kidney in DOCA-salt hypertensive rats].
    Liu LM; Yoshimi T
    Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):587-96. PubMed ID: 7796923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
    Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
    J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats.
    Schiffrin EL; St-Louis J
    Hypertension; 1987 May; 9(5):504-12. PubMed ID: 3032791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
    Zhang PL; Jiménez W; Mackenzie HS; Guo J; Troy JL; Ros J; Angeli P; Arroyo V; Brenner BM
    J Am Soc Nephrol; 1994 Oct; 5(4):1099-105. PubMed ID: 7849249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension.
    Kohno M; Horio T; Yoshiyama M; Takeda T
    Hypertension; 1992 Feb; 19(2):206-11. PubMed ID: 1531333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
    Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
    Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors.
    Imura R; Sano T; Goto J; Yamada K; Matsuda Y
    Mol Pharmacol; 1992 Dec; 42(6):982-90. PubMed ID: 1362244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
    Sano T; Morishita Y; Matsuda Y; Yamada K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):825-31. PubMed ID: 1346647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma brain natriuretic peptide levels in DOCA-salt hypertensive rats: relation to blood pressure and cardiac concentration.
    Yokota N; Aburaya M; Yamamoto Y; Kato J; Kitamura K; Kida O; Eto T; Minamino N; Kangawa K; Matsuo H
    Biochem Biophys Res Commun; 1990 Dec; 173(2):632-8. PubMed ID: 2148083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
    Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension.
    Kohzuki M; Abe K; Yasujima M; Kasai Y; Hiwatari M; Kanazawa M; Sato M; Omata K; Kudo K; Takeuchi K
    Tohoku J Exp Med; 1989 Apr; 157(4):301-11. PubMed ID: 2525826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody.
    Itoh H; Nakao K; Mukoyama M; Arai H; Yamada T; Saito Y; Shiono S; Hosoda K; Shirakami G; Suga S
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):39-44. PubMed ID: 1706603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of brain natriuretic peptide-45, a circulating form of rat brain natriuretic peptide, in spontaneously hypertensive rats.
    Kita T; Kida O; Yokota N; Eto T; Minamino N; Kangawa K; Matsuo H; Tanaka K
    Eur J Pharmacol; 1991 Sep; 202(1):73-9. PubMed ID: 1664804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.